BR0208786A - Métodod para identificação de proteìnas de bactérias intracelulares - Google Patents
Métodod para identificação de proteìnas de bactérias intracelularesInfo
- Publication number
- BR0208786A BR0208786A BR0208786-3A BR0208786A BR0208786A BR 0208786 A BR0208786 A BR 0208786A BR 0208786 A BR0208786 A BR 0208786A BR 0208786 A BR0208786 A BR 0208786A
- Authority
- BR
- Brazil
- Prior art keywords
- proteins
- secreted
- identification
- identified
- methods
- Prior art date
Links
- 230000003834 intracellular effect Effects 0.000 title abstract 3
- 108010077805 Bacterial Proteins Proteins 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 6
- 102000004169 proteins and genes Human genes 0.000 abstract 6
- 241000894006 Bacteria Species 0.000 abstract 2
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- -1 nucleic acid compounds Chemical class 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000009962 secretion pathway Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/81—Protease inhibitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Genetics & Genomics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Reproductive Health (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Computational Biology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28251301P | 2001-04-09 | 2001-04-09 | |
| DKPA200100581 | 2001-04-09 | ||
| PCT/DK2002/000234 WO2002082091A2 (en) | 2001-04-09 | 2002-04-09 | Method for identification of proteins from intracellular bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0208786A true BR0208786A (pt) | 2004-03-09 |
Family
ID=26069005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0208786-3A BR0208786A (pt) | 2001-04-09 | 2002-04-09 | Métodod para identificação de proteìnas de bactérias intracelulares |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1412757A2 (xx) |
| JP (1) | JP2004534526A (xx) |
| KR (1) | KR20040002905A (xx) |
| CN (1) | CN1531653A (xx) |
| BR (1) | BR0208786A (xx) |
| CA (1) | CA2443813A1 (xx) |
| IL (1) | IL158136A0 (xx) |
| MX (1) | MXPA03009222A (xx) |
| WO (1) | WO2002082091A2 (xx) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| US7576206B2 (en) | 2003-08-14 | 2009-08-18 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| US7223745B2 (en) | 2003-08-14 | 2007-05-29 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| GB0409748D0 (en) * | 2004-04-30 | 2004-06-09 | Chiron Srl | Lactoferrin cleavage |
| US7468383B2 (en) | 2005-02-11 | 2008-12-23 | Cephalon, Inc. | Proteasome inhibitors and methods of using the same |
| EP2152303A4 (en) | 2007-05-01 | 2011-10-05 | Univ Texas | CHLAMYDIA ANTIGENS AS REAGENTS FOR THE DIAGNOSIS AND TREATMENT OF CHLAMYDIA INFECTION AND DISEASE |
| US7892567B2 (en) | 2007-10-01 | 2011-02-22 | Board Of Regents, The University Of Texas System | Methods and compositions for immunization against chlamydial infection and disease |
| JP2012505212A (ja) | 2008-10-09 | 2012-03-01 | ボード・オヴ・リージェンツ，ユニヴァーシティ・オヴ・テキサス・システム | クラミジア感染および疾患の診断および治療のためのクラミジア抗原に関する方法および組成物 |
| AU2010341530B2 (en) | 2009-12-22 | 2016-03-10 | Cephalon, Inc. | Proteasome inhibitors and processes for their preparation, purification and use |
| CN102749233A (zh) * | 2012-06-04 | 2012-10-24 | 王新华 | 一种maldi-tof ms直接检测感染尿液病原菌前处理方法 |
| NL2019320B1 (en) * | 2017-03-02 | 2018-09-21 | Biosparq B V | Diagnostic method and system for diagnosis |
| CN112175955B (zh) * | 2020-10-29 | 2022-05-24 | 西南大学 | 一种在植物花粉中特异表达的强启动子cp09及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001515064A (ja) * | 1997-08-15 | 2001-09-18 | フランソワ・スーシー | クラスト−ラクタシスチンβ−ラクトンおよびそのアナログの合成 |
| KR20010032336A (ko) * | 1997-11-21 | 2001-04-16 | 브랑디 빠스깔 | 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
| KR100769103B1 (ko) * | 1997-11-28 | 2007-10-23 | 세로노 제네틱스 인스티튜트 에스.에이. | 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
-
2002
- 2002-04-09 CA CA002443813A patent/CA2443813A1/en not_active Abandoned
- 2002-04-09 JP JP2002579810A patent/JP2004534526A/ja active Pending
- 2002-04-09 MX MXPA03009222A patent/MXPA03009222A/es unknown
- 2002-04-09 KR KR10-2003-7013236A patent/KR20040002905A/ko not_active Application Discontinuation
- 2002-04-09 WO PCT/DK2002/000234 patent/WO2002082091A2/en not_active Application Discontinuation
- 2002-04-09 EP EP02759766A patent/EP1412757A2/en not_active Withdrawn
- 2002-04-09 BR BR0208786-3A patent/BR0208786A/pt not_active IP Right Cessation
- 2002-04-09 IL IL15813602A patent/IL158136A0/xx unknown
- 2002-04-09 CN CNA028091140A patent/CN1531653A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL158136A0 (en) | 2004-03-28 |
| MXPA03009222A (es) | 2004-11-12 |
| JP2004534526A (ja) | 2004-11-18 |
| EP1412757A2 (en) | 2004-04-28 |
| CN1531653A (zh) | 2004-09-22 |
| WO2002082091A3 (en) | 2004-03-04 |
| KR20040002905A (ko) | 2004-01-07 |
| CA2443813A1 (en) | 2002-10-17 |
| WO2002082091A2 (en) | 2002-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20040712B1 (hr) | Anti-amiloidna beta antitijela i njihova uporaba | |
| BRPI0511118A (pt) | polipeptìdeos de haemophilus influenzae não transcritos | |
| BR0208786A (pt) | Métodod para identificação de proteìnas de bactérias intracelulares | |
| ECSP088262A (es) | Proteínas de fusión de albúmina | |
| BR9910089A (pt) | Composições e antìgenos de neisseria meningitidis | |
| CY1116285T1 (el) | Ανασυνδυασμενες ν-γλυκοζυλιωμενες πρωτεϊνες απο προκαρυωτικα κυτταρα | |
| BR9814276A (pt) | Antìgenos de superfìcie | |
| ATE382053T1 (de) | System zur antikörperexpression und- synthese | |
| MX348154B (es) | Anticuerpos de enlace a il-1-beta y fragmentos de los mismos. | |
| ATE454393T1 (de) | Egvii-endoglucanase und dafür codierende nukleinsäuren | |
| DE50112802D1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
| DE60144201D1 (de) | Lawsonia intracellularis Impfstoff | |
| FR2827866B1 (fr) | Peptides synthetiques ou naturels liant la proteine phosphatase 2a, methode d'identification et utilisations | |
| Korir et al. | Proteomic studies of Plasmodium knowlesi SICA variant antigens demonstrate their relationship with P. falciparum EMP1 | |
| DE602004025265D1 (de) | Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon | |
| BR9812791A (pt) | Sequências de ácido nucléico associadas à virulência e seu uso | |
| IL162568A (en) | Isolated nucleic acid encoding a fluorescent mutant of an aequorea coerulescens protein | |
| BR0011469A (pt) | Gm-csf equina | |
| CY1105947T1 (el) | Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων | |
| BR0009775A (pt) | Método para melhorar a migração e invasão de mioblastos no contexto de terapia genética | |
| BR0312274A (pt) | polipeptìdeos imunogênicos de mycoplasma hyopneumoniae | |
| ZA200602107B (en) | Piroplasmid vaccine | |
| ATE278011T1 (de) | Human dnase ii | |
| BR0308180A (pt) | protéinas de superfìcie de leptospira | |
| ATE556135T1 (de) | Neues protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A,7A E 8A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010. |